Inverness Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$681K Buy
9,579
+717
+8% +$51K 0.04% 107
2022
Q2
$682K Sell
8,862
-90
-1% -$6.93K 0.04% 98
2022
Q1
$654K Buy
8,952
+72
+0.8% +$5.26K 0.03% 111
2021
Q4
$554K Hold
8,880
0.02% 111
2021
Q3
$525K Sell
8,880
-375
-4% -$22.2K 0.02% 118
2021
Q2
$618K Sell
9,255
-325
-3% -$21.7K 0.02% 108
2021
Q1
$605K Buy
9,580
+650
+7% +$41K 0.03% 99
2020
Q4
$554K Hold
8,930
0.02% 95
2020
Q3
$538K Sell
8,930
-965
-10% -$58.1K 0.02% 95
2020
Q2
$582K Sell
9,895
-2,394
-19% -$141K 0.03% 89
2020
Q1
$685K Buy
12,289
+2,269
+23% +$126K 0.04% 80
2019
Q4
$643K Buy
10,020
+325
+3% +$20.9K 0.03% 85
2019
Q3
$492K Sell
9,695
-150
-2% -$7.61K 0.03% 83
2019
Q2
$446K Sell
9,845
-260
-3% -$11.8K 0.02% 83
2019
Q1
$482K Sell
10,105
-2,450
-20% -$117K 0.03% 81
2018
Q4
$653K Sell
12,555
-760
-6% -$39.5K 0.04% 83
2018
Q3
$827K Buy
13,315
+460
+4% +$28.6K 0.04% 84
2018
Q2
$711K Sell
12,855
-569
-4% -$31.5K 0.04% 86
2018
Q1
$849K Buy
13,424
+2,459
+22% +$156K 0.05% 90
2017
Q4
$672K Sell
10,965
-800
-7% -$49K 0.04% 75
2017
Q3
$750K Buy
11,765
+200
+2% +$12.8K 0.05% 75
2017
Q2
$644K Sell
11,565
-400
-3% -$22.3K 0.04% 73
2017
Q1
$634K Sell
11,965
-40
-0.3% -$2.12K 0.04% 75
2016
Q4
$592K Sell
12,005
-4,257
-26% -$210K 0.04% 73
2016
Q3
$877K Sell
16,262
-1,460
-8% -$78.7K 0.07% 67
2016
Q2
$1.3M Buy
17,722
+227
+1% +$16.7K 0.1% 63
2016
Q1
$1.12M Sell
17,495
-455
-3% -$29.1K 0.09% 60
2015
Q4
$1.24M Sell
17,950
-5,895
-25% -$406K 0.09% 62
2015
Q3
$1.41M Buy
23,845
+175
+0.7% +$10.4K 0.12% 61
2015
Q2
$1.58M Sell
23,670
-1,170
-5% -$77.9K 0.11% 65
2015
Q1
$1.6M Buy
24,840
+640
+3% +$41.3K 0.12% 65
2014
Q4
$1.43M Sell
24,200
-275
-1% -$16.2K 0.11% 65
2014
Q3
$1.25M Buy
24,475
+3,562
+17% +$182K 0.1% 67
2014
Q2
$1.01M Buy
20,913
+5,293
+34% +$257K 0.08% 72
2014
Q1
$811K Sell
15,620
-25
-0.2% -$1.3K 0.06% 76
2013
Q4
$832K Hold
15,645
0.07% 79
2013
Q3
$724K Sell
15,645
-150
-0.9% -$6.94K 0.06% 78
2013
Q2
$706K Buy
+15,795
New +$706K 0.06% 73